Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) Beneish M-Score: -2.04 (As of Aug. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02291 Lepu Scientech Medical Technology (Shanghai) Co Ltd HKSE:02291
76 GF Score
Price HK$12.18
GF Value HK$44.29
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Lepu Scientech Medical Technology (Shanghai) Co Beneish M-Score?

Lepu Scientech Medical Technology (Shanghai) Co HKSE:02291 +6.75% 76 Beneish M-Score is -2.04 as of Aug. 20, 2026. GuruFocus rates HKSE:02291 with a GF Score™ of 76/100 and a GF Value™ of HK$44.29 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 768 Medical Devices & Instruments companies, Lepu Scientech Medical Technology (Shanghai) Co ranks worse than 79.43% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.04 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Lepu Scientech Medical Technology (Shanghai) Co's Beneish M-Score or its related term are showing as below:

HKSE:02291' s Beneish M-Score Range Over the Past 10 Years
Min: -4.26   Med: -2.04   Max: -0.83
Current: -2.04

During the past 7 years, the highest Beneish M-Score of Lepu Scientech Medical Technology (Shanghai) Co was -0.83. The lowest was -4.26. And the median was -2.04.


Lepu Scientech Medical Technology (Shanghai) Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Lepu Scientech Medical Technology (Shanghai) Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lepu Scientech Medical Technology (Shanghai) Co Beneish M-Score Chart

Lepu Scientech Medical Technology (Shanghai) Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial -4.26 -0.93 -2.61 -0.83 -2.04

Lepu Scientech Medical Technology (Shanghai) Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.61 0.00 -0.83 0.00 -2.04

HKSE:02291 vs ABT, SYK, MDT: Beneish M-Score Comparison

For the Medical Devices subindustry, Lepu Scientech Medical Technology (Shanghai) Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lepu Scientech Medical Technology (Shanghai) Co Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lepu Scientech Medical Technology (Shanghai) Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Lepu Scientech Medical Technology (Shanghai) Co's Beneish M-Score falls into.


HKSE:02291
76GF Score
Lepu Scientech Medical Technology (Shanghai) Co Ltd HKSE:02291
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lepu Scientech Medical Technology (Shanghai) Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Lepu Scientech Medical Technology (Shanghai) Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1678+0.528 * 1.062+0.404 * 1.0026+0.892 * 1.1582+0.115 * 0.7982
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0141+4.679 * 0.008878-0.327 * 0.7096
=-2.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was HK$104.3 Mil.
Revenue was HK$583.2 Mil.
Gross Profit was HK$493.8 Mil.
Total Current Assets was HK$1,577.9 Mil.
Total Assets was HK$2,318.7 Mil.
Property, Plant and Equipment(Net PPE) was HK$132.6 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$2.6 Mil.
Selling, General, & Admin. Expense(SGA) was HK$61.3 Mil.
Total Current Liabilities was HK$67.0 Mil.
Long-Term Debt & Capital Lease Obligation was HK$0.9 Mil.
Net Income was HK$264.8 Mil.
Gross Profit was HK$0.0 Mil.
Cash Flow from Operations was HK$244.2 Mil.
Total Receivables was HK$77.1 Mil.
Revenue was HK$503.6 Mil.
Gross Profit was HK$452.7 Mil.
Total Current Assets was HK$1,513.3 Mil.
Total Assets was HK$2,224.0 Mil.
Property, Plant and Equipment(Net PPE) was HK$128.8 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$2.0 Mil.
Selling, General, & Admin. Expense(SGA) was HK$52.2 Mil.
Total Current Liabilities was HK$90.1 Mil.
Long-Term Debt & Capital Lease Obligation was HK$1.6 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(104.315 / 583.233) / (77.124 / 503.561)
=0.178856 / 0.153157
=1.1678

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(452.725 / 503.561) / (493.761 / 583.233)
=0.899047 / 0.846593
=1.062

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1577.891 + 132.595) / 2318.736) / (1 - (1513.343 + 128.783) / 2223.994)
=0.26232 / 0.261632
=1.0026

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=583.233 / 503.561
=1.1582

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1.97 / (1.97 + 128.783)) / (2.551 / (2.551 + 132.595))
=0.015067 / 0.018876
=0.7982

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(61.296 / 583.233) / (52.189 / 503.561)
=0.105097 / 0.10364
=1.0141

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.854 + 67.029) / 2318.736) / ((1.616 + 90.135) / 2223.994)
=0.029276 / 0.041255
=0.7096

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(264.834 - 0 - 244.249) / 2318.736
=0.008878

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Lepu Scientech Medical Technology (Shanghai) Co has a M-score of -2.04 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.04 mean?
Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) has a Beneish M-Score of -2.04 as of Aug. 20, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Lepu Scientech Medical Technology (Shanghai) Co and its competitors. According to the industry distribution chart, Lepu Scientech Medical Technology (Shanghai) Co ranks #610 out of 768 companies in the Medical Devices & Instruments industry, placing it in the top 79.4%.
Is Lepu Scientech Medical Technology (Shanghai) Co's Beneish M-Score too high?
Lepu Scientech Medical Technology (Shanghai) Co's current Beneish M-Score is -2.04. Based on the distribution chart, Lepu Scientech Medical Technology (Shanghai) Co ranks #610 out of 768 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Lepu Scientech Medical Technology (Shanghai) Co has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lepu Scientech Medical Technology (Shanghai) Co's Beneish M-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Lepu Scientech Medical Technology (Shanghai) Co ranks #610 out of 768 companies for Beneish M-Score. This places Lepu Scientech Medical Technology (Shanghai) Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Lepu Scientech Medical Technology (Shanghai) Co and its competitors. Lepu Scientech Medical Technology (Shanghai) Co's current Beneish M-Score is -2.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lepu Scientech Medical Technology (Shanghai) Co stock overvalued right now?
Based on GuruFocus' analysis, Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$44.29, compared to a current price of HK$12.18 — trading 72.5% below its estimated fair value. The current Beneish M-Score is -2.04. Lepu Scientech Medical Technology (Shanghai) Co's overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291), the current Beneish M-Score is -2.04 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) Overvalued in 2026?

Based on GuruFocus' analysis, Lepu Scientech Medical Technology (Shanghai) Co stock appears to be undervalued. The current stock price of HK$12.18 is trading 72.5% below its estimated GF Value™ of HK$44.29. GuruFocus considers Lepu Scientech Medical Technology (Shanghai) Co to be Significantly Undervalued.

Key valuation signals for HKSE:02291:

  • Beneish M-Score: -2.04
  • GF Value™: HK$44.29 vs. price of HK$12.18 (72.5% below fair value)
  • GF Score™: 76/100 with 1 warning sign

No single metric tells the full story. See the HKSE:02291 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lepu Scientech Medical Technology (Shanghai) Co Business Description

Address No. 258, Xinzhuan Road, 1st Floor, 5th Floor Building 41, Songjiang District, Shanghai, CHN, 201612
Lepu Scientech Medical Technology (Shanghai) Co Ltd is focused on the research and development, manufacture, and commercialization of heart disease interventional medical devices. The reporting segments of the Group are as follows: The Occluder business segment and The heart valve business segment. The company generates majority of its revenue from the Occluder segment which is engaged in the research and development, manufacturing and sales of interventional treatment series occluders for the defective congenital heart disease.
76GF Score

Get the complete analysis for HKSE:02291

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$12.18
Price
HK$44.29
GF Value